Experimental treatment approaches

Over the past two decades, HIV treatment has evolved from AZT (zidovudine, Retrovir) monotherapy to the current standard of care – highly active antiretroviral therapy (HAART) consisting of combination regimens that include three or more drugs from at least two different classes.

Despite the clear benefits of modern HIV therapy, treatment is not without its drawbacks, including immediate side-effects, long-term problems related to drug toxicity, difficulty with adherence and high cost. As such, researchers have explored various alternative treatment strategies such as regimen simplification, induction and maintenance therapy, alternating regimens and structured treatment interruption.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.